Metraipolis › archive › dc_16747fb6dc73

Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial — Europe PMC PMID:41894094

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41894094
DOI
10.1007/s12185-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-07T23:19:44.949Z
SHA-256 of the archived text
62b1c50fcfc4d7d76738da6d68072e65d96e90b98474e66144d56ed2c5dc4039
Stable URL of this page
https://metraipolis.com/documento/dc_16747fb6dc73

How to cite

Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial — Europe PMC PMID:41894094 — Europe PMC (en), https://europepmc.org/article/MED/41894094 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_16747fb6dc73 (Metraipolis archive dc_16747fb6dc73, sha256 62b1c50fcfc4d7d76738da6d68072e65d96e90b98474e66144d56ed2c5dc4039)
BibTeX
@misc{dc16747fb6dc73,
  title = {Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial — Europe PMC PMID:41894094},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41894094},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_16747fb6dc73; sha256 62b1c50fcfc4d7d76738da6d68072e65d96e90b98474e66144d56ed2c5dc4039},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41894094. Agents can read the archived copy with the MCP tool read_document.